The illicit marketplace and associated misuse of medications has expanded to protect substitute substances [1], like New Psychoactive Substances (NPSs). NPSs comprise a heterogenous group of substances [2], such as prescription drugs and analysis chemicals, which are not managed under the 1961 One Convention on Narcotic Prescription drugs or perhap